Connection

Michael Ostrowski to Trans-Activators

This is a "connection" page, showing publications Michael Ostrowski has written about Trans-Activators.
Connection Strength

2.845
  1. Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele. PLoS One. 2017; 12(9):e0184984.
    View in: PubMed
    Score: 0.515
  2. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem. 2007 May 25; 282(21):15921-9.
    View in: PubMed
    Score: 0.249
  3. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Mol Cell Biol. 2007 Jun; 27(11):4018-27.
    View in: PubMed
    Score: 0.249
  4. Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model. J Immunol. 2004 Jul 15; 173(2):1374-9.
    View in: PubMed
    Score: 0.206
  5. Ets-2 interacts with co-repressor BS69 to repress target gene expression. Anticancer Res. 2003 May-Jun; 23(3A):2173-8.
    View in: PubMed
    Score: 0.190
  6. Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter. J Biol Chem. 2003 May 16; 278(20):17876-84.
    View in: PubMed
    Score: 0.188
  7. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Mol Cell Biol. 2000 Nov; 20(21):8026-34.
    View in: PubMed
    Score: 0.160
  8. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol Cell Biol. 1998 Sep; 18(9):5148-56.
    View in: PubMed
    Score: 0.137
  9. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines. Cancer Res. 1998 May 15; 58(10):2253-9.
    View in: PubMed
    Score: 0.135
  10. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol. 1996 Feb; 16(2):538-47.
    View in: PubMed
    Score: 0.115
  11. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol Cell Biol. 1992 Dec; 12(12):5355-62.
    View in: PubMed
    Score: 0.092
  12. Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice. J Cell Physiol. 2009 Jul; 220(1):230-7.
    View in: PubMed
    Score: 0.073
  13. PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter. J Cell Physiol. 2008 Jun; 215(3):636-44.
    View in: PubMed
    Score: 0.067
  14. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene. 2005 Jun 23; 24(27):4370-9.
    View in: PubMed
    Score: 0.055
  15. CD13/APN transcription is induced by RAS/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells. J Biol Chem. 2003 Dec 05; 278(49):49358-68.
    View in: PubMed
    Score: 0.049
  16. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem. 2003 Jun 27; 278(26):24209-16.
    View in: PubMed
    Score: 0.047
  17. A central role for Ets-2 in the transcriptional regulation and cyclic adenosine 5'-monophosphate responsiveness of the human chorionic gonadotropin-beta subunit gene. Mol Endocrinol. 2003 Jan; 17(1):11-26.
    View in: PubMed
    Score: 0.046
  18. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum Mol Genet. 2002 Jul 15; 11(15):1687-96.
    View in: PubMed
    Score: 0.045
  19. Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU.1. Blood. 1999 Jul 01; 94(1):127-38.
    View in: PubMed
    Score: 0.036
  20. Control of interferon-tau gene expression by Ets-2. Proc Natl Acad Sci U S A. 1998 Jul 07; 95(14):7882-7.
    View in: PubMed
    Score: 0.034
  21. Interaction between PU.1 and another Ets family transcription factor promotes macrophage-specific Basal transcription initiation. J Biol Chem. 1998 Mar 20; 273(12):6662-9.
    View in: PubMed
    Score: 0.033
  22. Involvement of Ets, rel and Sp1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages. J Inflamm. 1998; 48(2):67-83.
    View in: PubMed
    Score: 0.033
  23. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol Cell Biol. 1997 May; 17(5):2401-12.
    View in: PubMed
    Score: 0.031
  24. Regulation of CSF-1 receptor expression. Mol Reprod Dev. 1997 Jan; 46(1):46-52; discussion 52-3.
    View in: PubMed
    Score: 0.031
  25. Regulation of the murine TRACP gene promoter. J Bone Miner Res. 2003 Oct; 18(10):1901-4.
    View in: PubMed
    Score: 0.012
  26. TFEC is a macrophage-restricted member of the microphthalmia-TFE subfamily of basic helix-loop-helix leucine zipper transcription factors. J Immunol. 1999 Feb 01; 162(3):1559-65.
    View in: PubMed
    Score: 0.009
  27. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways. Mol Endocrinol. 1996 Sep; 10(9):1084-94.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.